Supplements

Combination medication treatment prolongs sleep latency and alters cognitive-related cortical hemodynamics in narcolepsy type 1 patients

In a pilot study of 16 drug-naive narcolepsy type 1 (NT1) patients, combination medication treatment significantly prolonged REM latency and mean sleep latency from MSLT, and reduced REM sleep proportion. During a verbal fluency task, fNIRS showed increased HbO2 in frontopolar, middle temporal, and subcentral areas, and decreased HbO2 in retrosplenial and dorsolateral prefrontal cortices. Pre-treatment HbO2 change in subcentral area and post-treatment HbO2 change in middle temporal gyrus predicted post-treatment mean sleep latency.

Last updated: Aug 30, 2026โ€ข0 RCTsโ€ข๐Ÿ“– Read as article โ†’

Evidence Score

Evidence Score32/100
Human RCTโ˜†โ˜†โ˜†โ˜†โ˜†
Meta-analysisโ˜†โ˜†โ˜†โ˜†โ˜†
Mechanismโ˜…โ˜…โ˜…โ˜…โ˜…
Safetyโ˜…โ˜…โ˜…โ˜…โ˜†
Confidencelow

Study Evidence

Study 1. Medication Treatment Modulates Sleep Architecture and Cognitive-Related Cortical Hemodynamics in Narcolepsy Type 1.

observational

Zhuofeng M, Xinyu K, Haodong Z, Zhenzhen Q, Lijing J, Fulong X, Weiping W ยท Nature and science of sleep (2026)

Participants: N/A
Duration: Not specified (pre-post intervention)
Intervention: Combination medication treatment (specific drugs not detailed in abstract)
Outcome: Sleep architecture (PSG, MSLT), cognitive-related cortical hemodynamics (fNIRS during VFT and Go/NoGo tasks), mean sleep latency
Effect Size: N/A
Population: 16 drug-naive narcolepsy type 1 (NT1) patients

Result:

Mechanism Graph

Medication treatment modulates sleep architecture, prolonging sleep latency and reducing REM proportion
โ†“
Treatment induces task-specific changes in cortical hemodynamics during verbal fluency, with increased HbO2 in some regions and decreased in others
โ†“
fNIRS-derived HbO2 changes in specific cortical areas predict post-treatment sleep latency
โ†“
Result: Combination therapy is associated with improved sleep latency and altered cognitive-related brain activity

Limitations

  • โš Exploratory pilot study with small sample size (n=16)
  • โš Specific medications and doses not reported in abstract
  • โš No control group; within-subject pre-post design
  • โš fNIRS findings require validation in larger independent cohorts

Frequently Asked Questions

What is the main finding of this study?โ–ผ

Combination medication treatment in narcolepsy type 1 patients significantly prolonged sleep latency (REM latency and mean sleep latency from MSLT) and reduced REM sleep proportion, while also altering cortical hemodynamics during a verbal fluency task.

How was cortical hemodynamics measured?โ–ผ

Cortical hemodynamics were measured using functional near-infrared spectroscopy (fNIRS) during Verbal Fluency Test (VFT) and Go/NoGo tasks, tracking changes in oxyhemoglobin (HbO2) concentration.

Which brain areas showed significant changes after treatment?โ–ผ

During VFT, HbO2 increased in frontopolar area, middle temporal gyrus, and subcentral area, and decreased in retrosplenial cortex (BA 29/30) and dorsolateral prefrontal cortex. No significant changes were found during Go/NoGo task.

Can fNIRS predict treatment response?โ–ผ

Yes, pre-treatment HbO2 change in subcentral area and post-treatment HbO2 change in middle temporal gyrus predicted post-treatment mean sleep latency, suggesting fNIRS parameters may serve as non-invasive biomarkers, but this needs validation.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Zhuofeng M, Xinyu K, Haodong Z, Zhenzhen Q, Lijing J, Fulong X, Weiping W. "Medication Treatment Modulates Sleep Architecture and Cognitive-Related Cortical Hemodynamics in Narcolepsy Type 1.." Nature and science of sleep, 2026. PMID: 42656325 DOI: 10.2147/NSS.S612135
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.